About the Company
We do not have any company description for VERU INC. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $VERU News
Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11
About Veru Inc. Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The Company’s drug ...
Veru (VERU) Price Target Decreased by 15.38% to 2.81
The average one-year price target for Veru (NasdaqCM:VERU) has been revised to 2.80 / share. This is an decrease of 15.38% ...
Veru Inc (VERU) Stock: A Look at the Analyst Recommendations
To put it simply, Veru Inc (VERU) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth ...
3 Standout Penny Stocks to Watch This April
Investing in penny stocks \- generally, stocks that trade for less than $5 per share or have small market caps and low floats ...
Veru Inc (VERU) Volatility Hits 16.29% – Here Is What You Should Do
Veru Inc (NASDAQ:VERU) concluded the trading at $1.24 Wednesday, April 10, with a rise of 5.98% from its closing price on previous day. Taking a look at stock we notice that its last check on previous ...
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new ...
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Wedbush raised PVH Corp. PVH price target from $113 to $128. Wedbush analyst Tom Nikic upgraded the stock from Neutral to ...
COVID-19 Drug Pipeline Landscape Report 2024: Comprehensive Insights on 400+ Companies and 400+ Pipeline Drugs
Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "COVID-19 - Pipeline Insight, 2024," report provides comprehensive insights about 400+ companies and ...
World Metastatic Prostate Cancer Drug Landscape Research Report 2024: Comprehensive Insights about 90+ Companies and 110+ Pipeline Drugs
The "Metastatic Prostate Cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about 90+ companies and 110+ ...
NRx Pharmaceuticals: New Data Demonstrates No Impact Of NRX-101 On Gut Or Vaginal Flora
NRx Pharmaceuticals, Inc. (NRXP) reported new data that demonstrate that in a rodent model NRX-101 shows no measurable damage to ...
Loading the latest forecasts...